ロード中...
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer
Despite extensive efforts, there has been limited progress in optimizing treatment of ovarian cancer patients. The vast majority of patients experience recurrence within a few years despite a high response rate to upfront therapy. The minimal improvement in overall survival of ovarian cancer patient...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562901/ https://ncbi.nlm.nih.gov/pubmed/31091744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050668 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|